Variations in white blood count, thromboxane B2 levels and hematocrit in chronic venous hypertension

OBJECTIVE: To analyze variations in leukocyte count and thromboxane B2 production in the femoral vein of patients with chronic venous hypertension (CVH). DESIGN: Prospective clinical study, controlled, non randomized and open. LOCATION: Hospital das Clínicas, Faculdade de Medicina da Universidade de...

Full description

Bibliographic Details
Main Authors: Paulo Celso Motta Guimarães, Pedro Puech-Leão, Baptista Muraco Netto, Nelson Wolosker, Ricardo Aun, Lídia Uraco Yamamoto
Format: Article
Language:English
Published: Associação Paulista de Medicina
Series:São Paulo Medical Journal
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801998000300006&lng=en&tlng=en
_version_ 1818160979915046912
author Paulo Celso Motta Guimarães
Pedro Puech-Leão
Baptista Muraco Netto
Nelson Wolosker
Ricardo Aun
Lídia Uraco Yamamoto
author_facet Paulo Celso Motta Guimarães
Pedro Puech-Leão
Baptista Muraco Netto
Nelson Wolosker
Ricardo Aun
Lídia Uraco Yamamoto
author_sort Paulo Celso Motta Guimarães
collection DOAJ
description OBJECTIVE: To analyze variations in leukocyte count and thromboxane B2 production in the femoral vein of patients with chronic venous hypertension (CVH). DESIGN: Prospective clinical study, controlled, non randomized and open. LOCATION: Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, referral center, university hospital. PARTICIPANTS: 15 patients with recurring stasis ulcer were analyzed, selected randomly from the venous diseases outpatient center, and 4 without lower limb venous alterations were also analyzed. INTERVENTION: Blood samples from the femoral and brachial veins were drawn following supine and 45º reverse Trendelenburg. MAIN OUTCOMES MEASURES: Direct leukocyte count and analysis of the thomboxane B2 with enzyme linked immunosorbent assay test. RESULTS: After 30 minutes in reverse Trendelenburg, patients with CVH showed a leukocyte count reduced by ±27% (p=0.02) and thromboxane B2 levels increased by ±158% (p=0.02). CONCLUSIONS: We suggest that future studies of medications for stasis ulcers include their effects on leukocyte entrapment and thromboxane B2 production in the lower limb venous system.
first_indexed 2024-12-11T16:10:29Z
format Article
id doaj.art-b4e1fbe551d9487b8ca0ef43728abe28
institution Directory Open Access Journal
issn 1806-9460
language English
last_indexed 2024-12-11T16:10:29Z
publisher Associação Paulista de Medicina
record_format Article
series São Paulo Medical Journal
spelling doaj.art-b4e1fbe551d9487b8ca0ef43728abe282022-12-22T00:59:05ZengAssociação Paulista de MedicinaSão Paulo Medical Journal1806-946011631721172610.1590/S1516-31801998000300006S1516-31801998000300006Variations in white blood count, thromboxane B2 levels and hematocrit in chronic venous hypertensionPaulo Celso Motta Guimarães0Pedro Puech-Leão1Baptista Muraco Netto2Nelson Wolosker3Ricardo Aun4Lídia Uraco Yamamoto5Universidade de São PauloUniversidade de São PauloUniversidade de São PauloUniversidade de São PauloUniversidade de São PauloUniversidade de São PauloOBJECTIVE: To analyze variations in leukocyte count and thromboxane B2 production in the femoral vein of patients with chronic venous hypertension (CVH). DESIGN: Prospective clinical study, controlled, non randomized and open. LOCATION: Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, referral center, university hospital. PARTICIPANTS: 15 patients with recurring stasis ulcer were analyzed, selected randomly from the venous diseases outpatient center, and 4 without lower limb venous alterations were also analyzed. INTERVENTION: Blood samples from the femoral and brachial veins were drawn following supine and 45º reverse Trendelenburg. MAIN OUTCOMES MEASURES: Direct leukocyte count and analysis of the thomboxane B2 with enzyme linked immunosorbent assay test. RESULTS: After 30 minutes in reverse Trendelenburg, patients with CVH showed a leukocyte count reduced by ±27% (p=0.02) and thromboxane B2 levels increased by ±158% (p=0.02). CONCLUSIONS: We suggest that future studies of medications for stasis ulcers include their effects on leukocyte entrapment and thromboxane B2 production in the lower limb venous system.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801998000300006&lng=en&tlng=enVenous ulcersVenous insufficiencyWhite blood countThromboxane B2
spellingShingle Paulo Celso Motta Guimarães
Pedro Puech-Leão
Baptista Muraco Netto
Nelson Wolosker
Ricardo Aun
Lídia Uraco Yamamoto
Variations in white blood count, thromboxane B2 levels and hematocrit in chronic venous hypertension
São Paulo Medical Journal
Venous ulcers
Venous insufficiency
White blood count
Thromboxane B2
title Variations in white blood count, thromboxane B2 levels and hematocrit in chronic venous hypertension
title_full Variations in white blood count, thromboxane B2 levels and hematocrit in chronic venous hypertension
title_fullStr Variations in white blood count, thromboxane B2 levels and hematocrit in chronic venous hypertension
title_full_unstemmed Variations in white blood count, thromboxane B2 levels and hematocrit in chronic venous hypertension
title_short Variations in white blood count, thromboxane B2 levels and hematocrit in chronic venous hypertension
title_sort variations in white blood count thromboxane b2 levels and hematocrit in chronic venous hypertension
topic Venous ulcers
Venous insufficiency
White blood count
Thromboxane B2
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801998000300006&lng=en&tlng=en
work_keys_str_mv AT paulocelsomottaguimaraes variationsinwhitebloodcountthromboxaneb2levelsandhematocritinchronicvenoushypertension
AT pedropuechleao variationsinwhitebloodcountthromboxaneb2levelsandhematocritinchronicvenoushypertension
AT baptistamuraconetto variationsinwhitebloodcountthromboxaneb2levelsandhematocritinchronicvenoushypertension
AT nelsonwolosker variationsinwhitebloodcountthromboxaneb2levelsandhematocritinchronicvenoushypertension
AT ricardoaun variationsinwhitebloodcountthromboxaneb2levelsandhematocritinchronicvenoushypertension
AT lidiauracoyamamoto variationsinwhitebloodcountthromboxaneb2levelsandhematocritinchronicvenoushypertension